Safety of Herbal Products in Thailand An Analysis of Reports in the Thai Health Product Vigilance Center Database from 2000 to 2008

Background: The use of herbal products continues to expand rapidly across the world and concerns regarding the safety of these products have been raised. In Thailand, Thai Vigibase, developed by the Health Product Vigilance Center (HPVC) under the Thai Food and Drug Administration, is the national d...

Full description

Saved in:
Bibliographic Details
Published inDrug safety Vol. 34; no. 4; pp. 339 - 350
Main Authors Saokaew, Surasak, Suwankesawong, Wimon, Permsuwan, Unchalee, Chaiyakunapruk, Nathorn
Format Journal Article
LanguageEnglish
Published Cham Springer International Publishing 01.04.2011
Adis International
Wolters Kluwer Health, Inc
Subjects
Online AccessGet full text
ISSN0114-5916
1179-1942
DOI10.2165/11586590-000000000-00000

Cover

Abstract Background: The use of herbal products continues to expand rapidly across the world and concerns regarding the safety of these products have been raised. In Thailand, Thai Vigibase, developed by the Health Product Vigilance Center (HPVC) under the Thai Food and Drug Administration, is the national database that collates reports from health product surveillance systems and programmes. Thai Vigibase can be used to identify signals of adverse events in patients receiving herbal products. Objectives: The purpose of the study was to describe the characteristics of reported adverse events in patients receiving herbal products in Thailand. Methods: Thai Vigibase data from February 2000 to December 2008 involving adverse events reported in association with herbal products were used. This database includes case reports submitted through the spontaneous reporting system and intensive monitoring programmes. Under the spontaneous reporting system, adverse event reports are collected nationwide via a national network of 22 regional centres covering more than 800 public and private hospitals, and health service centres. An intensive monitoring programme was also conducted to monitor the five single herbal products listed in the Thai National List of Essential Medicines (NLEM), while another intensive monitoring programme was developed to monitor the four single herbal products that were under consideration for inclusion in the NLEM. The database contained patient demographics, adverse events associated with herbal products, and details on seriousness, causality and quality of reports. Descriptive statistics were used for data analyses. Results: A total of 593 reports with 1868 adverse events involving 24 different products were made during the study period. The age range of individuals was 1–86 years (mean 47 years). Most case reports were obtained from the intensive monitoring programme. Of the reports, 72% involved females. The herbal products for which adverse events were frequently reported were products containing turmeric (44%), followed by andrographis (10%), veld grape (10%), pennywort (7%), plai (6%), jewel vine (6%), bitter melon (5%) and snake plant (5%). Gastrointestinal problems were the most common adverse effect reported. Serious adverse events included Stevens-Johnson syndrome, anaphylactic shock and exfoliative dermatitis. Conclusions: Adverse event reports on herbals products were diverse, with most of them being reported through intensive monitoring programmes. Thai Vigibase is a potentially effective data source for signal detection of adverse events associated with herbal products.
AbstractList Background: The use of herbal products continues to expand rapidly across the world and concerns regarding the safety of these products have been raised. In Thailand, Thai Vigibase, developed by the Health Product Vigilance Center (HPVC) under the Thai Food and Drug Administration, is the national database that collates reports from health product surveillance systems and programmes. Thai Vigibase can be used to identify signals of adverse events in patients receiving herbal products. Objectives: The purpose of the study was to describe the characteristics of reported adverse events in patients receiving herbal products in Thailand. Methods: Thai Vigibase data from February 2000 to December 2008 involving adverse events reported in association with herbal products were used. This database includes case reports submitted through the spontaneous reporting system and intensive monitoring programmes. Under the spontaneous reporting system, adverse event reports are collected nationwide via a national network of 22 regional centres covering more than 800 public and private hospitals, and health service centres. An intensive monitoring programme was also conducted to monitor the five single herbal products listed in the Thai National List of Essential Medicines (NLEM), while another intensive monitoring programme was developed to monitor the four single herbal products that were under consideration for inclusion in the NLEM. The database contained patient demographics, adverse events associated with herbal products, and details on seriousness, causality and quality of reports. Descriptive statistics were used for data analyses. Results: A total of 593 reports with 1868 adverse events involving 24 different products were made during the study period. The age range of individuals was 1-86 years (mean 47 years). Most case reports were obtained from the intensive monitoring programme. Of the reports, 72% involved females. The herbal products for which adverse events were frequently reported were products containing turmeric (44%), followed by andrographis (10%), veld grape (10%), pennywort (7%), plai (6%), jewel vine (6%), bitter melon (5%) and snake plant (5%). Gastrointestinal problems were the most common adverse effect reported. Serious adverse events included Stevens-Johnson syndrome, anaphylactic shock and exfoliative dermatitis. Conclusions: Adverse event reports on herbals products were diverse, with most of them being reported through intensive monitoring programmes. Thai Vigibase is a potentially effective data source for signal detection of adverse events associated with herbal products.
Background: The use of herbal products continues to expand rapidly across the world and concerns regarding the safety of these products have been raised. In Thailand, Thai Vigibase, developed by the Health Product Vigilance Center (HPVC) under the Thai Food and Drug Administration, is the national database that collates reports from health product surveillance systems and programmes. Thai Vigibase can be used to identify signals of adverse events in patients receiving herbal products. Objectives: The purpose of the study was to describe the characteristics of reported adverse events in patients receiving herbal products in Thailand. Methods: Thai Vigibase data from February 2000 to December 2008 involving adverse events reported in association with herbal products were used. This database includes case reports submitted through the spontaneous reporting system and intensive monitoring programmes. Under the spontaneous reporting system, adverse event reports are collected nationwide via a national network of 22 regional centres covering more than 800 public and private hospitals, and health service centres. An intensive monitoring programme was also conducted to monitor the five single herbal products listed in the Thai National List of Essential Medicines (NLEM), while another intensive monitoring programme was developed to monitor the four single herbal products that were under consideration for inclusion in the NLEM. The database contained patient demographics, adverse events associated with herbal products, and details on seriousness, causality and quality of reports. Descriptive statistics were used for data analyses. Results: A total of 593 reports with 1868 adverse events involving 24 different products were made during the study period. The age range of individuals was 1–86 years (mean 47 years). Most case reports were obtained from the intensive monitoring programme. Of the reports, 72% involved females. The herbal products for which adverse events were frequently reported were products containing turmeric (44%), followed by andrographis (10%), veld grape (10%), pennywort (7%), plai (6%), jewel vine (6%), bitter melon (5%) and snake plant (5%). Gastrointestinal problems were the most common adverse effect reported. Serious adverse events included Stevens-Johnson syndrome, anaphylactic shock and exfoliative dermatitis. Conclusions: Adverse event reports on herbals products were diverse, with most of them being reported through intensive monitoring programmes. Thai Vigibase is a potentially effective data source for signal detection of adverse events associated with herbal products.
The use of herbal products continues to expand rapidly across the world and concerns regarding the safety of these products have been raised. In Thailand, Thai Vigibase, developed by the Health Product Vigilance Center (HPVC) under the Thai Food and Drug Administration, is the national database that collates reports from health product surveillance systems and programmes. Thai Vigibase can be used to identify signals of adverse events in patients receiving herbal products. The purpose of the study was to describe the characteristics of reported adverse events in patients receiving herbal products in Thailand. Thai Vigibase data from February 2000 to December 2008 involving adverse events reported in association with herbal products were used. This database includes case reports submitted through the spontaneous reporting system and intensive monitoring programmes. Under the spontaneous reporting system, adverse event reports are collected nationwide via a national network of 22 regional centres covering more than 800 public and private hospitals, and health service centres. An intensive monitoring programme was also conducted to monitor the five single herbal products listed in the Thai National List of Essential Medicines (NLEM), while another intensive monitoring programme was developed to monitor the four single herbal products that were under consideration for inclusion in the NLEM. The database contained patient demographics, adverse events associated with herbal products, and details on seriousness, causality and quality of reports. Descriptive statistics were used for data analyses. A total of 593 reports with 1868 adverse events involving 24 different products were made during the study period. The age range of individuals was 1-86 years (mean 47 years). Most case reports were obtained from the intensive monitoring programme. Of the reports, 72% involved females. The herbal products for which adverse events were frequently reported were products containing turmeric (44%), followed by andrographis (10%), veld grape (10%), pennywort (7%), plai (6%), jewel vine (6%), bitter melon (5%) and snake plant (5%). Gastrointestinal problems were the most common adverse effect reported. Serious adverse events included Stevens-Johnson syndrome, anaphylactic shock and exfoliative dermatitis. Adverse event reports on herbals products were diverse, with most of them being reported through intensive monitoring programmes. Thai Vigibase is a potentially effective data source for signal detection of adverse events associated with herbal products.
Audience Academic
Author Suwankesawong, Wimon
Permsuwan, Unchalee
Chaiyakunapruk, Nathorn
Saokaew, Surasak
Author_xml – sequence: 1
  givenname: Surasak
  surname: Saokaew
  fullname: Saokaew, Surasak
  organization: School of Pharmacy, University of Phayao
– sequence: 2
  givenname: Wimon
  surname: Suwankesawong
  fullname: Suwankesawong, Wimon
  organization: Health Product Vigilance Center (HPVC), Food and Drug Administration, Ministry of Public Health
– sequence: 3
  givenname: Unchalee
  surname: Permsuwan
  fullname: Permsuwan, Unchalee
  organization: Department of Pharmaceutical Care, Faculty of Pharmacy, Chiang Mai University
– sequence: 4
  givenname: Nathorn
  surname: Chaiyakunapruk
  fullname: Chaiyakunapruk, Nathorn
  email: chaiyakunapr@wisc.edu
  organization: Center of Pharmaceutical Outcomes Research (CPOR), Department of Pharmacy Practice, Faculty of Pharmaceutical Sciences, Naresuan University, School of Population Health, University of Queensland, School of Pharmacy, University of Wisconsin-Madison
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=23985005$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/21417506$$D View this record in MEDLINE/PubMed
BookMark eNqNkVFLHTEQhUNR6lX7F2ShSJ_WZrKb3eRFEGm1IFSoPodsMrGRvYkmuw_--0b23kqLoMlDhvCdM8OcfbITYkBCKqAnDDr-FYCLjkta0-1Zqg9kBdDLGmTLdsiKArQ1l9Dtkf2c7wsgWCc-kj0GLfScdity_Es7nJ6q6KpLTIMeq-sU7WymXPlQ3fzWftTBHpJdp8eMnzbvAbn9_u3m_LK--nnx4_zsqjatbKa6ExyMbpwQGg3vGQ4Mew2md62z0mLbc8aMEGDk0ErqAI3VA-9pIzUwa5sD8mXxfUjxccY8qbXPBscyA8Y5K1G0BWaikJ8X8k6PqHxwcUraPNPqjHHWNS3nslAnr1DlWlx7U3bqfPn_R3C0GWAe1mjVQ_JrnZ7UdmEFON4AOhs9uqSD8fmFa6TglPLCnS6cSTHnhE4ZP-nJx1Am8KMCqp6TVNsk1d8kl6oYiP8Mtj3eIZWLNBdJuMOk7uOcQgnube0fLQms9Q
CitedBy_id crossref_primary_10_1016_j_imr_2020_100469
crossref_primary_10_1007_s40264_013_0055_5
crossref_primary_10_1016_j_sajb_2022_06_042
crossref_primary_10_1111_nep_12531
crossref_primary_10_1002_pds_5190
crossref_primary_10_1016_j_jopr_2013_08_007
crossref_primary_10_1111_jcpt_13106
crossref_primary_10_2196_63808
crossref_primary_10_1007_s11096_022_01533_1
crossref_primary_10_3109_15563650_2012_700402
crossref_primary_10_15406_ppij_2019_07_00257
crossref_primary_10_12688_f1000research_52946_1
crossref_primary_10_3389_fphar_2019_01205
crossref_primary_10_1186_1472_6882_14_515
crossref_primary_10_1371_journal_pone_0141993
crossref_primary_10_4236_health_2020_126044
crossref_primary_10_1097_MOP_0b013e328355a214
crossref_primary_10_3389_fmed_2018_00167
crossref_primary_10_1007_s40264_024_01480_y
crossref_primary_10_1016_S1665_2681_19_31464_4
crossref_primary_10_1515_jcim_2013_0016
crossref_primary_10_1007_s11096_011_9597_8
crossref_primary_10_29328_journal_acem_1001026
crossref_primary_10_1016_j_jep_2012_01_051
crossref_primary_10_1007_s00228_015_1898_8
Cites_doi 10.2165/00002018-200225060-00011
10.1046/j.1365-2125.1997.05417.x
10.1345/aph.1D027
10.1345/aph.1G185
10.1002/pds.1445
10.1345/aph.1C186
10.1016/j.amjmed.2003.10.036
10.1345/aph.1D486
10.1016/S1522-8401(00)90026-0
10.1345/aph.1K611
10.1345/aph.1D067
10.1016/j.clinthera.2005.11.004
10.1345/aph.1E460
10.1002/pds.1157
10.1345/aph.1K132
10.1345/aph.1A215
10.1046/j.1365-2125.1999.00060.x
10.2165/00002018-200730070-00006
10.1002/pds.1818
10.2165/00002018-200326120-00001
10.1002/j.1552-4604.1992.tb04635.x
10.1177/009286150804200501
ContentType Journal Article
Copyright Adis Data Information BV 2011
2015 INIST-CNRS
COPYRIGHT 2011 Wolters Kluwer Health, Inc.
Copyright_xml – notice: Adis Data Information BV 2011
– notice: 2015 INIST-CNRS
– notice: COPYRIGHT 2011 Wolters Kluwer Health, Inc.
DBID AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7T2
C1K
DOI 10.2165/11586590-000000000-00000
DatabaseName CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Health and Safety Science Abstracts (Full archive)
Environmental Sciences and Pollution Management
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Health & Safety Science Abstracts
Environmental Sciences and Pollution Management
DatabaseTitleList

MEDLINE
Health & Safety Science Abstracts
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Public Health
Pharmacy, Therapeutics, & Pharmacology
EISSN 1179-1942
EndPage 350
ExternalDocumentID A252634559
21417506
23985005
10_2165_11586590_000000000_00000
Genre Journal Article
GeographicLocations Thailand
Asia
GeographicLocations_xml – name: Thailand
GroupedDBID ---
-EM
04C
0R~
199
29G
2JY
36B
3V.
4.4
406
53G
5GY
5RE
6I2
6PF
7RV
7X7
88E
8FI
8FJ
8R4
8R5
95.
AAAUJ
AACDK
AADNT
AAIAL
AAIKX
AAJKR
AAKAS
AANZL
AARHV
AASML
AATNV
AAWTL
AAYOK
AAYQN
AAYTO
AAYZH
ABAKF
ABDZT
ABFTV
ABIPD
ABJNI
ABJOX
ABKCH
ABKMS
ABKTR
ABLLE
ABMNI
ABOCM
ABPLI
ABTKH
ABTMW
ABUWG
ABWHX
ABXPI
ACAOD
ACCOQ
ACCUX
ACDTI
ACGFO
ACGFS
ACMJI
ACMLO
ACOKC
ACPIV
ACPRK
ACREN
ACZOJ
ADBBV
ADFRT
ADFZG
ADJJI
ADQRH
ADRFC
ADURQ
ADYOE
ADZCM
ADZKW
AEBTG
AEFQL
AEJHL
AEJRE
AEMSY
AENEX
AEOHA
AEPYU
AESKC
AEVLU
AEXYK
AEYRQ
AFBBN
AFKRA
AFRAH
AFWTZ
AFZKB
AGAYW
AGDGC
AGQEE
AGQMX
AGRTI
AHIZS
AHMBA
AHSBF
AIAKS
AIGIU
AILAN
AIZAD
AJRNO
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMXSW
AMYLF
ASPBG
AVWKF
AWSVR
AXYYD
AZFZN
A~4
BENPR
BGNMA
BKEYQ
BPHCQ
BVXVI
BYPQX
CAG
CCPQU
COF
CS3
DCUDU
DNIVK
DPUIP
DU5
EBLON
EBS
EJD
EMOBN
ESX
EX3
F5P
FERAY
FIGPU
FLLZZ
FNLPD
FSGXE
FYUFA
HMCUK
IAO
IHR
IMOTQ
INH
INR
ITC
IWAJR
J-C
J5H
JZLTJ
L7B
LGEZI
LLZTM
LOTEE
M1P
M4Y
NADUK
NAPCQ
NQJWS
NU0
NXXTH
O9-
OAC
OPC
OVD
P2P
PQQKQ
PROAC
PSQYO
Q2X
ROL
RSV
RZALA
SISQX
SJYHP
SNPRN
SNX
SOHCF
SOJ
SPKJE
SRMVM
SSLCW
TEORI
TSG
U9L
UAX
UG4
UKHRP
UTJUX
VDBLX
VFIZW
W48
WAF
WOW
YFH
YQY
Z0Y
ZGI
ZXP
~JE
AAYXX
ABBRH
ABDBE
ABFSG
ACMFV
ACSTC
AEZWR
AFDZB
AFHIU
AFOHR
AHWEU
AIXLP
ATHPR
AYFIA
CITATION
PHGZM
PHGZT
ABRTQ
IQODW
PJZUB
PPXIY
CGR
CUY
CVF
ECM
EIF
NPM
AEIIB
PMFND
7T2
C1K
PUEGO
ID FETCH-LOGICAL-c493t-6851ca3f88aec572eb2e7a1c7f4fd9de47522c881c9b490f1ecdab57039a12dd3
ISSN 0114-5916
IngestDate Sun Sep 28 07:32:10 EDT 2025
Tue Jun 17 21:25:55 EDT 2025
Tue Jun 10 20:45:09 EDT 2025
Thu Jan 02 22:09:30 EST 2025
Mon Jul 21 09:16:22 EDT 2025
Tue Jul 01 00:37:47 EDT 2025
Thu Apr 24 22:58:23 EDT 2025
Fri Feb 21 02:28:14 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 4
Keywords Curcuma Longa
Community Pharmacist
Spontaneous Reporting System
Adverse Event Report
Herbal Product
Vigilance
Pharmacognosy
Toxicity
Plant origin
Database
Detection
Medicinal plant
Language English
License CC BY 4.0
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c493t-6851ca3f88aec572eb2e7a1c7f4fd9de47522c881c9b490f1ecdab57039a12dd3
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
PMID 21417506
PQID 888103928
PQPubID 23462
PageCount 12
ParticipantIDs proquest_miscellaneous_888103928
gale_infotracmisc_A252634559
gale_infotracacademiconefile_A252634559
pubmed_primary_21417506
pascalfrancis_primary_23985005
crossref_citationtrail_10_2165_11586590_000000000_00000
crossref_primary_10_2165_11586590_000000000_00000
springer_journals_10_2165_11586590_000000000_00000
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 20110400
PublicationDateYYYYMMDD 2011-04-01
PublicationDate_xml – month: 4
  year: 2011
  text: 20110400
PublicationDecade 2010
PublicationPlace Cham
PublicationPlace_xml – name: Cham
– name: Auckland
– name: New Zealand
PublicationTitle Drug safety
PublicationTitleAbbrev Drug-Safety
PublicationTitleAlternate Drug Saf
PublicationYear 2011
Publisher Springer International Publishing
Adis International
Wolters Kluwer Health, Inc
Publisher_xml – name: Springer International Publishing
– name: Adis International
– name: Wolters Kluwer Health, Inc
References Bruno, Ellis (CR10) 2005; 39
Meyboom, Lindquist, Egberts (CR23) 2002; 25
CR18
Eland, Belton, van Grootheest (CR25) 1999; 48
CR15
Egberts (CR29) 2007; 30
Lindquist (CR21) 2007; 30
Bianchi, Cantù, Firenzuoli (CR3) 2004; 38
Richard, Jurgens (CR6) 2005; 39
Lindquist (CR20) 2008; 42
(CR14) 2005
Bent, Ko (CR1) 2004; 116
Naranjo, Shear, Lactot (CR19) 1992; 32
Dennehy, Tsourounis, Miller (CR16) 2005; 39
Riewpaiboon (CR13) 2006; 15
Moride, Haramburu, Requejo (CR28) 2003; 43
Jacobosson, Jonsson, Gerden (CR27) 2009; 18
Sleeper, Kennedy (CR7) 2003; 37
Barnes (CR24) 2003; 26
Boullata, McDonnell, Oliva (CR5) 2003; 37
Ahmad, Goetsch, Marks, Strom (CR22) 2005
(CR8) 2004
CR9
Gryzlak, Wallace, Zimmerman (CR26) 2007; 16
Bottenberg, Wall, Harvey (CR4) 2007; 41
(CR30) 2004
Wallace, Gryzlak, Zimmerman (CR17) 2008; 42
Kennedy (CR11) 2005; 27
Burns (CR2) 2000; 1
Martin, Jordan, Vassar (CR12) 2002; 36
Eland (R25-8-20110318) 1999; 48
(R8-8-20110318) 2004
Dennehy (R16-8-20110318) 2005; 39
Naranjo (R19-8-20110318) 1992; 32
Wallace (R17-8-20110318) 2008; 42
Lindquist (R21-8-20110318) 2007; 30
Riewpaiboon (R13-8-20110318) 2006; 15
Lindquist (R20-8-20110318) 2008; 42
Gryzlak (R26-8-20110318) 2007; 16
Jacobosson (R27-8-20110318) 2009; 18
Richard (R6-8-20110318) 2005; 39
Moride (R28-8-20110318) 2003; 43
Barnes (R24-8-20110318) 2003; 26
Meyboom (R23-8-20110318) 2002; 25
Martin (R12-8-20110318) 2002; 36
Sleeper (R7-8-20110318) 2003; 37
Bottenberg (R4-8-20110318) 2007; 41
Boullata (R5-8-20110318) 2003; 37
Egberts (R29-8-20110318) 2007; 30
Bianchi (R3-8-20110318) 2004; 38
Burns (R2-8-20110318) 2000; 1
Bruno (R10-8-20110318) 2005; 39
(R30-8-20110318) 2004
Ahmad (R22-8-20110318) 2005
Kennedy (R11-8-20110318) 2005; 27
Bent (R1-8-20110318) 2004; 116
(R14-8-20110318) 2005
12773073 - Ann Pharmacother. 2003 Jun;37(6):832-5
17726067 - Ann Pharmacother. 2007 Oct;41(10 ):1740-3
1447396 - J Clin Pharmacol. 1992 Oct;32(10):897-904
15187214 - Ann Pharmacother. 2004 Jul-Aug;38(7-8):1222-5
16368456 - Clin Ther. 2005 Nov;27(11):1847-58
16159994 - Ann Pharmacother. 2005 Oct;39(10):1634-9
18397972 - Ann Pharmacother. 2008 May;42(5):653-60
9131950 - Br J Clin Pharmacol. 1997 Feb;43(2):177-81
10583035 - Br J Clin Pharmacol. 1999 Oct;48(4):623-7
17604412 - Drug Saf. 2007;30(7):607-9
12452745 - Ann Pharmacother. 2002 Dec;36(12):1862-9
17613175 - Pharmacoepidemiol Drug Saf. 2007 Sep;16(9):947-57
15741417 - Ann Pharmacother. 2005 Apr;39(4):643-8
16184619 - Pharmacoepidemiol Drug Saf. 2006 Sep;15(9):683-6
15047038 - Am J Med. 2004 Apr 1;116(7):478-85
12503940 - Ann Pharmacother. 2003 Jan;37(1):83-6
19650152 - Pharmacoepidemiol Drug Saf. 2009 Nov;18(11):1039-47
12071784 - Drug Saf. 2002;25(6):459-65
12959628 - Drug Saf. 2003;26(12 ):829-51
15741425 - Ann Pharmacother. 2005 Apr;39(4):712-20
References_xml – start-page: 134
  year: 2005
  end-page: 59
  ident: CR22
  article-title: Spontaneous reporting in the United States
  publication-title: Pharmacoepidemiology
– volume: 25
  start-page: 459
  issue: 6
  year: 2002
  end-page: 65
  ident: CR23
  article-title: Signal selection and follow-up in pharmacovigilance
  publication-title: Drug Saf
  doi: 10.2165/00002018-200225060-00011
– ident: CR18
– volume: 43
  start-page: 177
  issue: 2
  year: 2003
  end-page: 81
  ident: CR28
  article-title: Underreporting of adverse drug reactions in general practice
  publication-title: Br J Clin Pharmacol
  doi: 10.1046/j.1365-2125.1997.05417.x
– volume: 37
  start-page: 832
  year: 2003
  end-page: 5
  ident: CR5
  article-title: Anaphylactic reaction to a dietary supplement containing willow bark
  publication-title: Ann Pharmacother
  doi: 10.1345/aph.1D027
– volume: 39
  start-page: 1634
  year: 2005
  end-page: 9
  ident: CR16
  article-title: Evaluation of herbal dietary supplements marketed on the internet for recreational use
  publication-title: Ann Pharmacother
  doi: 10.1345/aph.1G185
– volume: 16
  start-page: 947
  year: 2007
  end-page: 57
  ident: CR26
  article-title: National surveillance of herbal dietary supplement exposure: the poison control center experience
  publication-title: Pharmacoepidemiol Drug Saf
  doi: 10.1002/pds.1445
– volume: 37
  start-page: 83
  year: 2003
  end-page: 6
  ident: CR7
  article-title: Adverse reaction to a dietary supplement in an elderly patient
  publication-title: Ann Pharmacother
  doi: 10.1345/aph.1C186
– volume: 116
  start-page: 478
  issue: 7
  year: 2004
  end-page: 85
  ident: CR1
  article-title: Commonly used herbal medicines in the United States: a review
  publication-title: Am J Med
  doi: 10.1016/j.amjmed.2003.10.036
– year: 2004
  ident: CR8
  publication-title: WHO guidelines on safety monitoring of herbal medicines in pharmacovigilance systems
– volume: 38
  start-page: 1222
  year: 2004
  end-page: 5
  ident: CR3
  article-title: Rhabdomyolysis caused by , a natural lipid-lowering agent
  publication-title: Ann Pharmacother
  doi: 10.1345/aph.1D486
– volume: 1
  start-page: 186
  issue: 3
  year: 2000
  end-page: 90
  ident: CR2
  article-title: Alternative medicine: herbal preparations
  publication-title: Clin Ped Emerg Med
  doi: 10.1016/S1522-8401(00)90026-0
– volume: 32
  start-page: 897
  year: 1992
  end-page: 904
  ident: CR19
  article-title: Advances in the diagnosis of adverse drug reactions
  publication-title: J Clin Pharmacol
– volume: 42
  start-page: 653
  year: 2008
  end-page: 60
  ident: CR17
  article-title: Application of FDA adverse event report data to the surveillance of dietary botanical supplements
  publication-title: Ann Pharmacother
  doi: 10.1345/aph.1K611
– volume: 39
  start-page: 712
  year: 2005
  end-page: 20
  ident: CR6
  article-title: Effects of natural health products on blood pressure
  publication-title: Ann Pharmacother
  doi: 10.1345/aph.1D067
– volume: 27
  start-page: 1847
  year: 2005
  end-page: 58
  ident: CR11
  article-title: Herb and supplement use in the US adult population
  publication-title: Clin Ther
  doi: 10.1016/j.clinthera.2005.11.004
– volume: 39
  start-page: 643
  year: 2005
  end-page: 8
  ident: CR10
  article-title: Herbal use among US elderly: 2002 national health interview survey
  publication-title: Ann Pharmacother
  doi: 10.1345/aph.1E460
– ident: CR15
– volume: 30
  start-page: 953
  issue: 10
  year: 2007
  ident: CR21
  article-title: Documentation grading of ICSRs and improved data quality management in Vigibase [abstract]
  publication-title: Drug Saf
– ident: CR9
– year: 2005
  ident: CR14
  publication-title: National policy on traditional medicine and regulation of herbal medicines: report of a WHO global survey
– year: 2004
  ident: CR30
  publication-title: Health products surveillance in community pharmacies
– volume: 15
  start-page: 683
  year: 2006
  end-page: 6
  ident: CR13
  article-title: Increasing herbal product consumption in Thailand
  publication-title: Pharmacoepidemiol Drug Saf
  doi: 10.1002/pds.1157
– volume: 41
  start-page: 1740
  year: 2007
  end-page: 3
  ident: CR4
  article-title: Oral aloe verainduced hepatitis
  publication-title: Ann Pharmacother
  doi: 10.1345/aph.1K132
– volume: 36
  start-page: 1862
  year: 2002
  end-page: 9
  ident: CR12
  article-title: Herbal and nonherbal alternative medicine use in northwest Ohio
  publication-title: Ann Pharmacother
  doi: 10.1345/aph.1A215
– volume: 48
  start-page: 623
  year: 1999
  end-page: 7
  ident: CR25
  article-title: Attitudinal survey of voluntary reporting of adverse drug reactions
  publication-title: Br J Clin Pharmacol
  doi: 10.1046/j.1365-2125.1999.00060.x
– volume: 30
  start-page: 607
  issue: 7
  year: 2007
  end-page: 9
  ident: CR29
  article-title: Signal detection: historical background
  publication-title: Drug Saf
  doi: 10.2165/00002018-200730070-00006
– volume: 18
  start-page: 1039
  issue: 11
  year: 2009
  end-page: 47
  ident: CR27
  article-title: Spontaneously reported adverse reactions in association with complementary and alternative medicine substances in Sweden
  publication-title: Pharmacoepidemiol Drug Saf
  doi: 10.1002/pds.1818
– volume: 42
  start-page: 409
  year: 2008
  end-page: 19
  ident: CR20
  article-title: VigiBase, the WHO global ICSR database system: basic facts
  publication-title: Drug Infor J
– volume: 26
  start-page: 829
  issue: 12
  year: 2003
  end-page: 51
  ident: CR24
  article-title: Pharmacovigilance of herbal medicines: a UK perspective
  publication-title: Drug Saf
  doi: 10.2165/00002018-200326120-00001
– volume: 116
  start-page: 478
  issue: 7
  year: 2004
  ident: R1-8-20110318
  publication-title: Am J Med
  doi: 10.1016/j.amjmed.2003.10.036
– year: 2005
  ident: R14-8-20110318
– volume: 18
  start-page: 1039
  issue: 11
  year: 2009
  ident: R27-8-20110318
  publication-title: Pharmacoepidemiol Drug Saf
  doi: 10.1002/pds.1818
– year: 2004
  ident: R30-8-20110318
– volume: 30
  start-page: 607
  issue: 7
  year: 2007
  ident: R29-8-20110318
  publication-title: Drug Saf
  doi: 10.2165/00002018-200730070-00006
– volume: 41
  start-page: 1740
  year: 2007
  ident: R4-8-20110318
  publication-title: Ann Pharmacother
  doi: 10.1345/aph.1K132
– volume: 36
  start-page: 1862
  year: 2002
  ident: R12-8-20110318
  publication-title: Ann Pharmacother
  doi: 10.1345/aph.1A215
– year: 2004
  ident: R8-8-20110318
– volume: 27
  start-page: 1847
  year: 2005
  ident: R11-8-20110318
  publication-title: Clin Ther
  doi: 10.1016/j.clinthera.2005.11.004
– volume: 38
  start-page: 1222
  year: 2004
  ident: R3-8-20110318
  publication-title: Ann Pharmacother
  doi: 10.1345/aph.1D486
– volume: 32
  start-page: 897
  year: 1992
  ident: R19-8-20110318
  publication-title: J Clin Pharmacol
  doi: 10.1002/j.1552-4604.1992.tb04635.x
– start-page: 134
  year: 2005
  ident: R22-8-20110318
– volume: 48
  start-page: 623
  year: 1999
  ident: R25-8-20110318
  publication-title: Br J Clin Pharmacol
  doi: 10.1046/j.1365-2125.1999.00060.x
– volume: 39
  start-page: 643
  year: 2005
  ident: R10-8-20110318
  publication-title: Ann Pharmacother
  doi: 10.1345/aph.1E460
– volume: 26
  start-page: 829
  issue: 12
  year: 2003
  ident: R24-8-20110318
  publication-title: Drug Saf
  doi: 10.2165/00002018-200326120-00001
– volume: 37
  start-page: 832
  year: 2003
  ident: R5-8-20110318
  publication-title: Ann Pharmacother
  doi: 10.1345/aph.1D027
– volume: 39
  start-page: 712
  year: 2005
  ident: R6-8-20110318
  publication-title: Ann Pharmacother
  doi: 10.1345/aph.1D067
– volume: 37
  start-page: 83
  year: 2003
  ident: R7-8-20110318
  publication-title: Ann Pharmacother
  doi: 10.1345/aph.1C186
– volume: 42
  start-page: 653
  year: 2008
  ident: R17-8-20110318
  publication-title: Ann Pharmacother
  doi: 10.1345/aph.1K611
– volume: 1
  start-page: 186
  issue: 3
  year: 2000
  ident: R2-8-20110318
  publication-title: Clin Ped Emerg Med
  doi: 10.1016/S1522-8401(00)90026-0
– volume: 42
  start-page: 409
  year: 2008
  ident: R20-8-20110318
  publication-title: Drug Infor J
  doi: 10.1177/009286150804200501
– volume: 16
  start-page: 947
  year: 2007
  ident: R26-8-20110318
  publication-title: Pharmacoepidemiol Drug Saf
  doi: 10.1002/pds.1445
– volume: 15
  start-page: 683
  year: 2006
  ident: R13-8-20110318
  publication-title: Pharmacoepidemiol Drug Saf
  doi: 10.1002/pds.1157
– volume: 25
  start-page: 459
  issue: 6
  year: 2002
  ident: R23-8-20110318
  publication-title: Drug Saf
  doi: 10.2165/00002018-200225060-00011
– volume: 43
  start-page: 177
  issue: 2
  year: 2003
  ident: R28-8-20110318
  publication-title: Br J Clin Pharmacol
  doi: 10.1046/j.1365-2125.1997.05417.x
– volume: 39
  start-page: 1634
  year: 2005
  ident: R16-8-20110318
  publication-title: Ann Pharmacother
  doi: 10.1345/aph.1G185
– volume: 30
  start-page: 953
  issue: 10
  year: 2007
  ident: R21-8-20110318
  publication-title: Drug Saf
– reference: 16184619 - Pharmacoepidemiol Drug Saf. 2006 Sep;15(9):683-6
– reference: 9131950 - Br J Clin Pharmacol. 1997 Feb;43(2):177-81
– reference: 1447396 - J Clin Pharmacol. 1992 Oct;32(10):897-904
– reference: 15741425 - Ann Pharmacother. 2005 Apr;39(4):712-20
– reference: 17613175 - Pharmacoepidemiol Drug Saf. 2007 Sep;16(9):947-57
– reference: 15047038 - Am J Med. 2004 Apr 1;116(7):478-85
– reference: 19650152 - Pharmacoepidemiol Drug Saf. 2009 Nov;18(11):1039-47
– reference: 12959628 - Drug Saf. 2003;26(12 ):829-51
– reference: 12071784 - Drug Saf. 2002;25(6):459-65
– reference: 12773073 - Ann Pharmacother. 2003 Jun;37(6):832-5
– reference: 16159994 - Ann Pharmacother. 2005 Oct;39(10):1634-9
– reference: 17604412 - Drug Saf. 2007;30(7):607-9
– reference: 17726067 - Ann Pharmacother. 2007 Oct;41(10 ):1740-3
– reference: 15187214 - Ann Pharmacother. 2004 Jul-Aug;38(7-8):1222-5
– reference: 15741417 - Ann Pharmacother. 2005 Apr;39(4):643-8
– reference: 12503940 - Ann Pharmacother. 2003 Jan;37(1):83-6
– reference: 16368456 - Clin Ther. 2005 Nov;27(11):1847-58
– reference: 10583035 - Br J Clin Pharmacol. 1999 Oct;48(4):623-7
– reference: 12452745 - Ann Pharmacother. 2002 Dec;36(12):1862-9
– reference: 18397972 - Ann Pharmacother. 2008 May;42(5):653-60
SSID ssj0008268
Score 2.102396
Snippet Background: The use of herbal products continues to expand rapidly across the world and concerns regarding the safety of these products have been raised. In...
The use of herbal products continues to expand rapidly across the world and concerns regarding the safety of these products have been raised. In Thailand, Thai...
Background: The use of herbal products continues to expand rapidly across the world and concerns regarding the safety of these products have been raised. In...
Background The use of herbal products continues to expand rapidly across the world and concerns regarding the safety of these products have been raised. In...
SourceID proquest
gale
pubmed
pascalfrancis
crossref
springer
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 339
SubjectTerms Adolescent
Adult
Adverse Drug Reaction Reporting Systems - statistics & numerical data
Aged
Aged, 80 and over
Andrographis
Biological and medical sciences
Child
Child, Preschool
Clinical trial. Drug monitoring
Curcuma longa
Data Interpretation, Statistical
Databases, Factual - statistics & numerical data
Drug Safety and Pharmacovigilance
Drug-Related Side Effects and Adverse Reactions - epidemiology
Drug-Related Side Effects and Adverse Reactions - etiology
Female
General pharmacology
Health aspects
Humans
Infant
Male
Medical sciences
Medicine
Medicine & Public Health
Medicine, Botanic
Medicine, Herbal
Middle Aged
Original Research Article
Pharmacognosy. Homeopathy. Health food
Pharmacology. Drug treatments
Pharmacology/Toxicology
Plant Preparations - adverse effects
Plant Preparations - standards
Retrospective Studies
Thailand
Vitaceae
Young Adult
Subtitle An Analysis of Reports in the Thai Health Product Vigilance Center Database from 2000 to 2008
Title Safety of Herbal Products in Thailand
URI https://link.springer.com/article/10.2165/11586590-000000000-00000
https://www.ncbi.nlm.nih.gov/pubmed/21417506
https://www.proquest.com/docview/888103928
Volume 34
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELe6TkJIE4LyFRiVH2A8sEDjOF-PYwxVSK0q1oq-RY5js6qQVk2jqTzyl3OOnaQdQxvrQ-QmuXz4Lnfn893PCL1WYiRpwmzJfGlTIZnNPCrsJGW-55LUd7mKQw6Gfn9Cv0y9aav1eytrqVgn7_mva-tK7sJV2Ad8VVWy_8HZ-qKwA9rAX9gCh2F7Kx6fMyl0RkUfegc6e6TxW8sc1_EFm5n1OWr389Oq-P4uL6nq0ApbzJnQEzzFiuWsLt05Ly5ZNhc5uzRpu99mP5tJ-xGo9FydoY5MMn4BlqYWklO494bNi4wtV4Ve5Qc8zcUq2w4yqKgp3Q4yVEHGK2HKJlK2HaF0qO1FjsG31loVvnrbieiO2jUxzNl2TKHUoa5GNzLm2NW4tFc1PXF8BYoB_mzoe1FZHK9_utVYtzrnEEY7iiiuSOKaRLf20D4JwP9qo_2PZ8PR19qewwCstOfVi-l8MHWtD_-6_Y6TY0z9wZLl8NlJvV7KdQOavybjSx9n_BA9MIMTfKIl7RFqiayD7g1M-kUHHY000PnmGI-bur38GB_hUQOBvumgAx0NxrrI7TF6oyUVLyTWkoorScWzDFeS-gRNPp-NT_u2WaDD5jRy17YP7jpnrgxDJrgXEJEQETCHB5LKNEoFDcC752Ho8CihUU86gqcsUZhvEXNImrpPUTtbZOI5wl7qsIRQ7qakR3mURoFHfZnIJOAuczmxUFD1aMwNer1aROVHfBNfLeTUlEuN4HILmreKabGSOLgLZ6ZWBZ5VwaXFJ8QjvkthNG6hw50zQTnzncPdHbbXT6BgNz2wgBbClRzEilalPGZiUeRxCP0GHUVCCz3T8tEQOxS8_p5vIVIJTGzUUn7ju724C9FLdL9RC4eovV4V4hV44-uki_aCadA1Hw38G44GfwBjzdGU
linkProvider ProQuest
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Safety+of+Herbal+Products+in+Thailand&rft.jtitle=Drug+safety&rft.au=Saokaew%2C+Surasak&rft.au=Suwankesawong%2C+Wimon&rft.au=Permsuwan%2C+Unchalee&rft.au=Chaiyakunapruk%2C+Nathorn&rft.date=2011-04-01&rft.pub=Springer+International+Publishing&rft.issn=0114-5916&rft.eissn=1179-1942&rft.volume=34&rft.issue=4&rft.spage=339&rft.epage=350&rft_id=info:doi/10.2165%2F11586590-000000000-00000&rft.externalDocID=10_2165_11586590_000000000_00000
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0114-5916&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0114-5916&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0114-5916&client=summon